Market Scenario:

A concussion is referred to a brain injury that inflicts trauma further affecting the brain function. The effects due to concussions are temporary and may induce problems such as headaches, memory problems, concentration, coordination, and balance. Usually, an individual requires seven to 10 days to recover from this condition. Furthermore, if a person sustains a concussion, he/she is susceptible to additional concussions. Repeated concussions may lead to long-term consequences and hence, prevention is essential. Degenerative brain diseases such as Chronic Traumatic Encephalopathy (CTE) are seen in military veterans, athletes, and others who are susceptible to repetitive brain trauma.

As per the survey conducted by the American Academy of Pediatrics (AAP) in the United States, concussions are considered as the most common type of injuries that requires medical care in case of children and adolescents. Concussions due to sports activities have become a significant problem.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5724

Factors such as the growing circumstances of brain injuries and accidents and the rising geriatric population are mainly driving the global concussions market. The complications of repeated concussions leading to brain trauma and high chances of recurrence are some of the factors hampering the growth of the market around the world. The growing health concerns and rising cases of sports injuries have driven the government to undertake numerous initiatives to spread awareness regarding these conditions thus creating opportunities for the growth of the global concussions market.

Global Concussions Market is expected to grow at a cagr of approximately 7.1% during the forecast period, 2017–2023.

Segmentation:

The global concussions market is segmented on the basis of diagnosis, type, treatment, and end-user.

On the basis of diagnosis, the global concussions market is segmented into imaging tests, neuropsychological assessment, balance assessment, and others. Imaging tests are further segmented into Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) scans, Electroencephalogram (EEG), and others.

On the basis of type, the global concussions market is segmented into mild (grade 1), moderate (grade 2), and severe (grade 3).

On the basis of treatment, the global concussions market is segmented into medications, therapies, supportive care, surgery, and others. The medication segment is further classified into analgesic, anti-nausea medication, and others.

On the basis of end-user, the market is segmented into hospitals, clinics, and others.

Regional Analysis:

The global concussions market consists of four regions such as the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominate the global concussions market owing to the increasing cases of brain injuries, improving overall healthcare infrastructure, expanding private healthcare sector, and economic growth. According to the Centers for Disease Control and Prevention (CDC), 4,35,000 cases of concussions and TBIs on an average are witnessed every year in children below the age of 14 years. Typically, the chances for concussions are high in children under the age of five and adolescents of 15 to 19 years of age. Males are twice as much prone to sustain concussion injuries as that of the female.

Moreover, the European region is the second largest market for global concussions due to the increasing cases of accidents, injuries due to sports activities, and advancements in the medical procedure. Moreover, these conditions have resulted in the adoption of the shock pad technology that began in Europe and is nowadays commercially available in the U.S.

Asia Pacific is the fastest growing region for concussions market due to the increasing demand for painkillers and analgesics by sports professionals and increasing R&D activities for the development of novel drugs.

The Middle Eastern and African region is growing at a steady pace contributing the lowest share of the global concussions market.

Key Players:

Some of key the players in the global concussions market are GlaxoSmithKline PLC (U.S.), Teva Pharmaceuticals Industries (Israel), Cadila Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Allergan PLC (U.S.), Mylan NV (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Sanofi (France), Nephron Pharmaceuticals (U.S.), Wockhardt Ltd. (India), Albemarle Corporation (U.S.), Shandong Xinhua Pharmaceutical Co.,Ltd. (U.S.), GRANULES (U.S.), Hubei Zhongtian Hengdi (China), Bayer AG (Germany), Boots (U.S.), Juhua Group Corporation (China), Lupin Pharmaceuticals (India), Baiyunshan (China), Hubei Prosperity GALAXY Chemical Co., Ltd. (China), BASF SE (Germany), Zibo Xinghua-Perrigo Pharmaceutical Co., Ltd (China), Dr.Reddy's Laboratories (India), Hubei Yuancheng Saichuang Technology Co., Ltd. (China), IOL Chemicals and Pharmaceuticals Limited (IOLCP) (India), Huazhong Yaoye (China), Ethyl Corporation (U.S.), Bubei Hongjing (China), Shanghai Shenqiang (China), Jingchu Chen Pharmaceutical (China), Chenmei (China), Sunline (U.S.), CorePharma, LLC (U.S.), Zhengzhou Huayao Biological Technology Co., Ltd (China), Wuhan Dinghui Chemical Co.,Ltd. (China), and others.


Browse Full Reports @ https://www.marketresearchfuture.com/reports/concussions-market-5724